OSL 9.09% 0.5¢ oncosil medical ltd

Ann: FDA Grants Breakthrough Device Designation, page-2

  1. 1,071 Posts.
    lightbulb Created with Sketch. 179
    great work OSL!!! achieving a great milstone into US market. OncoSil Medical receives FDA Breakthrough Device Designation for its device for the treatment of unresectable locally advanced pancreatic cancer in combination with systemic chemotherapy.
    next step is now to work closely with the FDA to ensure that the proposed premarket approval PMA
 
watchlist Created with Sketch. Add OSL (ASX) to my watchlist
(20min delay)
Last
0.5¢
Change
-0.001(9.09%)
Mkt cap ! $16.66M
Open High Low Value Volume
0.6¢ 0.6¢ 0.5¢ $62.00K 12.03M

Buyers (Bids)

No. Vol. Price($)
7 6487586 0.5¢
 

Sellers (Offers)

Price($) Vol. No.
0.6¢ 24090459 22
View Market Depth
Last trade - 16.10pm 28/05/2024 (20 minute delay) ?
Last
0.5¢
  Change
-0.001 ( 9.09 %)
Open High Low Volume
0.5¢ 0.5¢ 0.5¢ 6680000
Last updated 15.48pm 28/05/2024 ?
OSL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.